We have been covering the biomanufacturing workforce at length this year because it remains one of the most important topics for companies in today’s near full-employment job market.
As one of the world’s top bio hubs, the BioHealth Capital Region (BHCR) is rife with life science assets. The region has been at the forefront of the SARS-CoV-2 vaccine race and it is rapidly becoming a center for advanced manufacturing. The BHCR cell and gene therapy ecosystem is thriving, and the area boasts one of the richest and most diverse tapestries of life science talent and workforce development programming. What’s more, Maryland, Washington, DC, and Virginia are home to several dynamic university systems that keep the talent and tech transfer pipeline humming and full.
The Investor Relations website contains information about Altimmune’s business for stockholders, potential investors, and financial analysts.
2020 was a year like no other for BioHealth Capital Region (BCHR) biotechs, and this year is expected to bring substantial growth across many sectors.
Lonza Pharma and Biotech (Lonza) is one of the world’s leading contract development and manufacturing organizations with 37 sites across the U.S., Europe, Asia, and the Middle East.
Lonza’s Walkersville, Maryland site is seeking new talent to support a growing portfolio of exciting projects. As part of this hiring campaign, the Walkersville site is hosting a Virtual Recruiting Event on January 26th so that job candidates can learn more about Lonza, its culture, and the opportunities available at the Walkersville location, which is just a short drive from downtown Frederick, Maryland, one the region’s most popular destinations.
